<bill session="109" type="h" number="2077" updated="2019-11-15T21:48:28Z">
  <state datetime="2005-05-04">REFERRED</state>
  <status>
    <introduced datetime="2005-05-04"/>
  </status>
  <introduced datetime="2005-05-04"/>
  <titles>
    <title type="official" as="introduced">To suspend temporarily the duty on Garenoxacin mesylate.</title>
    <title type="display">To suspend temporarily the duty on Garenoxacin mesylate.</title>
  </titles>
  <sponsor bioguide_id="B000755"/>
  <cosponsors/>
  <actions>
    <action datetime="2005-05-04">
      <text>Introduced in House</text>
    </action>
    <action datetime="2005-05-04" state="REFERRED">
      <text>Referred to the House Committee on Ways and Means.</text>
    </action>
    <action datetime="2005-05-10">
      <text>Referred to the Subcommittee on Trade.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM04" name="House Ways and Means" subcommittee="Trade" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Foreign trade and international finance"/>
    <term name="Drugs"/>
    <term name="Health"/>
    <term name="Tariff"/>
  </subjects>
  <amendments/>
  <summary date="2005-06-20T20:09:39Z" status="Introduced in House">Amends the Harmonized Tariff Schedule of the United States to suspend, through December 31, 2008, the duty on 1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-5-isoindolyl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid monomethanesulfonate monohydrate (Garenoxacin mesylate).</summary>
</bill>
